HONEYGLOW
Live / Applied — Non-final action mailed (as of 07 Jan 2026)
What this means for you
Not registered yet, but its 19 Sept 2024 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 79417786
- Mark type
- Stylized text
- Filed
- 19 Sept 2024
- Attorney of record
- Nicole M. Meyer
Goods and services
- Class 001 — Chemicals: Chemical products, namely, chemical thickeners and perfluorinated chemical compounds sold as components for manufacturing cosmetic products, creams, lotions, soaps, perfumes and eau de Cologne, hair shampoos and hair emollients; preparations, namely, biological preparations, used as components in the manufacture of cosmetic products, creams, lotions, soaps, perfumes and eau de Cologne, hair shampoos and hair emollients; active chemical ingredients for use in the manufacture of cosmetics, moisturizing creams, creams, lotions, soaps, perfumes and eau de Cologne, hair shampoos and hair emollients; pharmaceuticals for manufacturing products intended for viral and infectious disease treatment, namely, antivirals, dantrolene sodium, chemical additives, glycerine, glycerol, polymers and polymeric additives, perfluorinated chemical compounds, excipients, dodium hyaluronate; active chemical ingredients for use in the manufacture of pharmaceuticals for treating viral and infectious diseases
- Class 003 — Cosmetics and cleaning preparations: Cosmetics; cosmetic preparations; facial moisturizers; body moisturizers; anti-aging creams; non-medicated skin serums; oral vaporizers; non-medicated preparations for skin care; perfumes; skin creams; skin lotions, namely, for cosmetic use; bath foams; bath oils; hair shampoos; hair conditioners, namely, emollients; eaux de toilette; eau de Cologne; aftershave; after-shave balms; non-medicated soaps for the face and body; talcum powders
- Class 005 — Pharmaceuticals: Pharmaceutical and nutraceutical preparations, namely, antioxidant, antimicrobial, dietary supplement, UV protectants, nutritional supplements plant extracts, polyphenol extracts, herbal extracts, serums, and vitamin preparation substances and ingredients, intended for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatologic, ophthalmological, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and infectious diseases, blood diseases, pain, inflammation, sepsis, alopecia, diabetes, cancer, obesity and cognitive disorders and diseases and disorders of the immune system; pharmaceutical preparations and substances for cancer treatment; biological ingredients, namely, antioxidant, antimicrobial, dietary supplement, nutritional supplements plant extract, polyphenol extract, terpene extracts, herbal extracts, serum, vitamin preparations and preparations for cancer treatment; pharmaceutical products and ingredients, for the treatment of viral and infectious diseases; nutraceuticals for use as dietary supplements; nutraceuticals and pharmaceuticals for the treatment of cancer, obesity, diabetes and other diseases and disorders; biological preparations for the treatment of cancer, obesity, diabetes and other diseases and disorders; biological reagents for medical use; nutritional supplements; bio-medicines, namely, antioxidant, antimicrobial, anti-cancer bioactives, plant extract, polyphenol extract, terpene extracts, herbal extracts, serum, vitamin preparations, sunscreens, wound healing cream or serum, scar healing cream or serums; biomedical products, namely, antioxidant, antimicrobial, dietary supplement, nutritional supplements, extracts, serum, wound healing creams or patches, scar healing creams or serums, vitamin preparations; veterinary products, namely, antioxidant, antimicrobial, dietary supplement, nutritional supplements, extracts, serum, wound healing creams or patches, scar healing creams or serums, vitamin preparations; biological preparations for the treatment of cancer, obesity, diabetes and other diseases and disorders namely, for veterinary use
Owner
Prosecution history
- 29 Jan 2026 — REFUSAL PROCESSED BY IB
- 07 Jan 2026 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 07 Jan 2026 — NON-FINAL ACTION E-MAILED
- 07 Jan 2026 — NON-FINAL ACTION WRITTEN
- 08 Dec 2025 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 08 Dec 2025 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 08 Dec 2025 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 01 Oct 2025 — ATTORNEY REVIEW COMPLETED
- 08 Sept 2025 — CORRECTION FROM IB ENTERED - ATTORNEY REVIEW REQUIRED
- 28 Jun 2025 — REFUSAL PROCESSED BY IB
- 06 Jun 2025 — NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
- 06 Jun 2025 — REFUSAL PROCESSED BY MPU
- 04 Apr 2025 — CORRECTION TRANSACTION RECEIVED FROM IB
- 02 Apr 2025 — NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
- 01 Apr 2025 — NON-FINAL ACTION WRITTEN